Clinical trial Recruiting at 2 sites Interventional Ages 18 to 80

How cochlear implants affect listening effort and understanding in everyday conversations

Official title: Cochlear Implants and Listening Effort: the Interaction of Cognitive and Sensory Constraints

Run by NYU Langone Health · NCT07279441 · Data updated 2026-11-12

The researchers will test whether measuring listening effort with pupil tracking and using realistic speech tasks can explain and improve how adults with cochlear implants understand everyday conversations.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment460 (estimated)
SponsorNYU Langone Health
Academic / other
Locations2 sites (Waltham, Massachusetts and 1 other locations)
StatusRecruiting
StartedJanuary 2, 2025
Main results expectedJanuary 2, 2030
Study endsJanuary 2, 2030
Registry record updatedOctober 30, 2026
Trial IDNCT07279441 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 who use cochlear implants, are native American English speakers, and have no neurologic, psychiatric, or non–hearing-related language disorders are ideal candidates.

Probably not a fit

People under 18, non-native speakers of American English, or individuals with neurologic, psychiatric, or language disorders beyond hearing loss are unlikely to be eligible or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research uses six connected experiments to study how adults with cochlear implants comprehend speech in realistic communication settings. The team combines pupillometry (pupil dilation as an index of listening effort) with behavioral speech-recognition and a validated discourse-comprehension framework that distinguishes main ideas from details. Experiments manipulate linguistic context, cognitive load (for example remembering multiple sentences), and processing time (including self-paced presentation), and include normal-hearing controls listening to vocoded speech. Participants aged 18–80 complete a comprehensive baseline battery and attend lab sessions at NYU Langone or Brandeis, with one experiment designed for clinical application.

Why it matters

Potential benefit: If successful, the results could lead to better tests and rehabilitation strategies that reduce listening effort and improve real-world communication for cochlear implant users.

How similar studies have gone: Prior laboratory work using pupillometry and vocoder simulations has linked listening effort to speech recognition, but applying these methods to longer discourse comprehension in cochlear implant users is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects will be otherwise healthy normal-hearing and cochlear implant (CI) adult listeners (between 18 and 80 years old).

Exclusion Criteria:

* Individuals below 18 years of age.
* Individuals with evidence of neurologic, vascular or psychiatric disease or dementia, and taking medications that might interfere with task performance.
* Individuals with a history of language disorders (besides those associated with hearing loss for the CI users). Individuals who are non-native speakers of American English.

Where it's running

  • Brandeis University
    Waltham, Massachusetts, United States
    Recruiting
  • NYU Langone Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.